Financials

Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-1.17
Price to sales ratio
1.56

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
3570
VYGR
Voyager Therapeutics, Inc. - Common Stock
3.54 USD+2.31%+4.42%+17.22%-23.87%218.13 M USD
3571
CHRS
Coherus Oncology, Inc. - Common Stock
1.41 USD-3.42%+0.71%-0.70%-12.42%217.85 M USD
3579
PEPG
PepGen Inc. - Common Stock
3.08 USD+0.33%-1.91%+79.07%+163.25%213.32 M USD
3582
BCYC
Bicycle Therapeutics plc - American Depositary Shares
4.20 USD-3.00%-3.00%+8.81%-42.23%212.33 M USD

Frequently asked questions about Precision BioSciences, Inc. Common Stock

What is the Precision BioSciences, Inc. Common Stock stock price today?

The current price of Precision BioSciences, Inc. Common Stock (DTIL) is 7.78. Over the past 24 hours, the stock has changed by -7.38%. Follow the DTIL chart for real-time price dynamics.

What is the stock ticker of Precision BioSciences, Inc. Common Stock?

Precision BioSciences, Inc. Common Stock trades under the ticker DTIL. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Precision BioSciences, Inc. Common Stock stock going up?

DTIL has changed by -11.79% over the last week, +12.10% over the last month, and +61.08% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of Precision BioSciences, Inc. Common Stock?

Precision BioSciences, Inc. Common Stock currently has a market capitalization of 214.74 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

What were Precision BioSciences, Inc. Common Stock earnings last quarter?

Last quarter, Precision BioSciences, Inc. Common Stock reported earnings of -1.26 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was Precision BioSciences, Inc. Common Stock revenue for the last quarter?

Precision BioSciences, Inc. Common Stock reported quarterly revenue of 0. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.

What was Precision BioSciences, Inc. Common Stock net income for the last quarter?

Precision BioSciences, Inc. Common Stock reported net income of -32.65 M for the last quarter. The previous quarter showed -18.44 M, which means net income changed by -77.06%.

How many employees does Precision BioSciences, Inc. Common Stock have?

As of the latest available data, Precision BioSciences, Inc. Common Stock has 67 employees. Workforce size can provide additional context about the company's scale and operations.

How can I buy Precision BioSciences, Inc. Common Stock stock?

You can buy Precision BioSciences, Inc. Common Stock (DTIL) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Precision BioSciences, Inc. Common Stock stock?

Investing in Precision BioSciences, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the DTIL chart and related analysis on metatrader.com as part of your research.

Precision BioSciences, Inc. - Common Stock

Precision BioSciences, Inc. is a publicly traded American clinical stage gene editing company headquartered in Durham, North Carolina. Founded in 2006, Precision is focused on developing both in vivo and ex vivo gene editing therapies using its proprietary "ARCUS" genome editing platform.

News